European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN)
Anna Bersano(University of the Sacred Heart), Dominique Hervé(Hôpital Lariboisière), Francesco Acerbi(University of Pisa), Sabrina Lémeret(European CanCer Organisation), Elisabeth Tournier‐Lasserve(Inserm), Blanca Fuentes(Hospital Universitario La Paz), Marialuisa Zedde(Azienda Sanitaria Unità Locale di Reggio Emilia), Peter Vajcoczy(Charité - Universitätsmedizin Berlin), Markus Kraemer(Alfried Krupp von Bohlen und Halbach Foundation), Nadia Khan(University of Zurich), Salman Hussain(European CanCer Organisation), Isabella Canavero(Fondazione IRCCS Istituto Neurologico Carlo Besta)
Cited by 82
Related Papers
Neuroimaging standards for research into small vessel disease—advances since 2013
|The Lancet Neurology|2023|962
The Control of Vascular Integrity by Endothelial Cell Junctions: Molecular Basis and Pathological Implications
|Developmental Cell|2009|782
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
|The Lancet Neurology|2015|464